SCHEMBL4629887

SCHEMBL4629887

CC(C)(C)OC(=O)N1CCC(C(N)=O)(c2ccc(Br)cc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ RORC P51449 3/20 0.48
▸ JAK2 O60674 1/20 0.46
▸ JAK1 P23458 1/20 0.46
▸ FPR2 P25090 6/20 0.43
▸ FPR3 P25089 5/20 0.43
▸ GPR119 Q8TDV5 2/20 0.42
▸ OPRD1 P41143 1/20 0.41
▸ OPRK1 P41145 1/20 0.41
▸ CTSD P07339 1/20 0.40
▸ CTSE P14091 1/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ ESRRB O95718 1/20 0.39
▸ ESR1 P03372 1/20 0.39
▸ ESRRA P11474 1/20 0.39
▸ ESRRG P62508 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12988312 0.88 TSHR (0.53) TSHRALOX15ATMRORCJAK2
SCHEMBL654889 0.87 KMT2A (0.53) TSHRALOX15ATMOPRD1OPRK1
SCHEMBL6543780 0.87 TSHR (0.63) TSHRALOX15ATMRORCJAK2
SCHEMBL26930774 0.86 TSHR (0.54) TSHRALOX15ATMRORCJAK2
SCHEMBL23660780 0.86 BACE1 (0.53) TSHRALOX15ATMGPR119CTSD
SCHEMBL26372781 0.86 GPR119 (0.52) TSHRALOX15ATMJAK2JAK1
SCHEMBL26930433 0.86 TSHR (0.51) TSHRALOX15ATMRORCJAK2
SCHEMBL19331220 0.85 TSHR (0.48) TSHRALOX15ATMRORCJAK2
SCHEMBL8353458 0.85 TSHR (0.49) TSHRALOX15ATMJAK2JAK1
SCHEMBL4630446 0.84 RORC (0.50) TSHRALOX15ATMRORCJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304549-A1 HYDROXYAMIDE DERIVATIVE AND USE THEREOF SICHUAN HUIYU PHARMACEUTICAL CO., LTD. (CN) 2025-10-02 — — US disclosed
EP-4509500-A1 HYDROXYAMIDE DERIVATIVE AND USE THEREOF Sichuan Huiyu Pharmaceutical Co., Ltd. (CN) 2025-02-19 — — EP disclosed
CN-119173510-A Hydroxy amide derivative and application thereof 四川汇宇制药股份有限公司 2024-12-20 — — CN disclosed
WO-2023222115-A1 HYDROXYAMIDE DERIVATIVE AND USE THEREOF 四川汇宇制药股份有限公司 2023-11-23 — — WO disclosed
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 — — EP disclosed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250304549-A1 HYDROXYAMIDE DERIVATIVE AND USE THEREOF HDAC1, HDAC11, HDAC5 TSHR 3472/4885ALOX15 2373/4885ATM 3258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback